MAINTRAC

//MAINTRAC
MAINTRAC 2017-03-02T15:36:20+00:00

MAINTRAC

The Principle

The number of existing washed out tumor-cells within the patient’s blood are counted. These developed tumor-cells can furthermore be visually characterized and provide additional conclusions with regards to:

[/fusion_builder_column]
  • Vital circulating tumor cells (HEA), quantitative
  • Growth activity (Her2/new amplification with FISH)
  • Mortality rate (apoptosis analysis with TUNEL essay)
  • Organ affiliation (specific antigens, such as PSA, Mel A)
  • Hormone receptor status

After the operation of a malignant tumor, the number and growth characteristics of residual circulating tumor cells in the patient’s blood or bone marrow are vital in order to determine his/her disease progression.

MAINTRAC offers you:

  • An accompanying and gentle method to additionally monitor the success rate of the applied  cancer therapy
[/fusion_builder_row][/fusion_builder_container]